BlackRock Inc. - BELLICUM PHARMACEUTICALS INC ownership

BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$1,300,000
+22.8%
1,007,837
-0.0%
0.00%
Q3 2019$1,059,000
-50.8%
1,008,232
-20.4%
0.00%
Q2 2019$2,151,000
-77.8%
1,265,899
-56.0%
0.00%
Q1 2019$9,685,000
+13.0%
2,874,253
-2.1%
0.00%
Q4 2018$8,570,000
-59.5%
2,935,508
-14.4%
0.00%
-100.0%
Q3 2018$21,137,000
-8.0%
3,431,193
+10.2%
0.00%0.0%
Q2 2018$22,970,000
+54.7%
3,112,394
+37.5%
0.00%0.0%
Q1 2018$14,847,000
-23.7%
2,263,186
-2.2%
0.00%0.0%
Q4 2017$19,462,000
-28.3%
2,314,166
-1.6%
0.00%0.0%
Q3 2017$27,151,000
+5.6%
2,350,761
+6.8%
0.00%0.0%
Q2 2017$25,713,000
+24.7%
2,201,509
+31.8%
0.00%0.0%
Q1 2017$20,618,000
+58808.6%
1,670,756
+64935.3%
0.00%
Q4 2016$35,000
-25.5%
2,569
+7.7%
0.00%
Q3 2016$47,000
+67.9%
2,386
+13.5%
0.00%
Q2 2016$28,000
+833.3%
2,102
+563.1%
0.00%
Q1 2016$3,000
-25.0%
317
+51.7%
0.00%
Q4 2015$4,000
-84.6%
209
-88.4%
0.00%
Q3 2015$26,000
+550.0%
1,809
+765.6%
0.00%
Q2 2015$4,000
-20.0%
2090.0%0.00%
Q1 2015$5,0002090.00%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
EMORY UNIVERSITY 95,215$1,297,0001.28%
Baker Brothers Advisors 4,865,647$66,270,0000.65%
Eventide Asset Management 250,000$3,405,0000.22%
MCDANIEL TERRY & CO 76,112$1,037,0000.22%
SUFFOLK CAPITAL MANAGEMENT LLC 82,538$1,124,0000.15%
QVT Financial LP 337,923$4,603,0000.14%
KENNEDY CAPITAL MANAGEMENT LLC 478,465$6,517,0000.11%
Vident Investment Advisory, LLC 47,157$642,0000.08%
Tekla Capital Management LLC 60,000$817,0000.04%
First Eagle Investment Management, LLC 775,254$10,559,0000.03%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders